Screener
Xeris Biopharma Holdings, Inc. XERS Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Xeris Biopharma Holdings, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001867096-26-000065
| Assets | June 30, 2026 / (unaudited) | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | 21,773 | 22,112 |
| Goodwill | 22,859 | 22,859 |
| Intangible assets, net | 82,657 | 88,078 |
| Other assets | 5,025 | 5,220 |
| Total assets | $411,905 | $383,527 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $9,337 | $3,076 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Xeris Biopharma Holdings, Inc.'s other non-current assets?
- Xeris Biopharma Holdings, Inc. (XERS) reported other non-current assets of $5.03M in Q2 2026.
- How has Xeris Biopharma Holdings, Inc.'s other non-current assets changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s other non-current assets decreased by 0.7% year-over-year, from $5.06M to $5.03M.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s other non-current assets has grown at a 86.4% compound annual growth rate (CAGR), from $232K to $5.22M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Xeris Biopharma Holdings, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude